43 results on '"Szymonifka, Jackie"'
Search Results
2. Primary Care Provider Density and Elective Total Joint Replacement Outcomes.
3. Validation of the Hip Disability and Osteoarthritis Outcome Score and Knee Injury and Osteoarthritis Outcome Score Pain and Function Subscales for Use in Total Hip Replacement and Total Knee Replacement Clinical Trials
4. Utility of Computed Tomography to Predict Ventricular Arrhythmias in Patients With Nonischemic Cardiomyopathy Receiving Cardiac Resynchronization Therapy
5. Computed Tomography−Guided Assessment of Response to Cardiac Resynchronization Therapy
6. Cardiorenal status using amino-terminal pro–brain natriuretic peptide and cystatin C on cardiac resynchronization therapy outcomes: From the BIOCRT Study
7. Diagnosing Prosthetic Joint Infections in Patients With Inflammatory Arthritis: A Systematic Literature Review
8. Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays
9. General Assembly, Diagnosis, Laboratory Test: Proceedings of International Consensus on Orthopedic Infections
10. Diagnostic Performance of Hybrid Cardiac Imaging Methods for Assessment of Obstructive Coronary Artery Disease Compared With Stand-Alone Coronary Computed Tomography Angiography
11. Development and Validation of a Simple-to-Use Nomogram for Predicting 5-, 10-, and 15-Year Survival in Asymptomatic Adults Undergoing Coronary Artery Calcium Scoring
12. A four-tier classification system of pulmonary artery metrics on computed tomography for the diagnosis and prognosis of pulmonary hypertension
13. CIRCULATING CONCENTRATIONS OF OREXIN A ARE ASSOCIATED WITH LEFT VENTRICULAR REVERSE REMODELING AND CLINICAL OUTCOMES FOLLOWING CARDIAC RESYNCHRONIZATION THERAPY
14. Diffuse coronary artery disease among other atherosclerotic plaque characteristics by coronary computed tomography angiography for predicting coronary vessel-specific ischemia by fractional flow reserve
15. Novel Heart Failure Biomarkers Predict Improvement of Mitral Regurgitation in Patients Receiving Cardiac Resynchronization Therapy—The BIOCRT Study
16. USEFULNESS OF ATHEROSCLEROTIC PLAQUE DIFFUSENESS AND VOLUME BY CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR PREDICTING CORONARY LESION-SPECIFIC ISCHEMIA BY FRACTIONAL FLOW RESERVE
17. DUAL-SOURCE COMPUTED TOMOGRAPHY TO IMPROVE PREDICTION OF RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY (DIRECT): A PROSPECTIVE DOUBLE-BLIND RANDOMIZED STUDY
18. SERIAL COMPUTED TOMOGRAPHY PULMONARY ARTERIAL MEASUREMENTS PREDICT SURVIVAL IN PULMONARY HYPERTENSION PATIENTS
19. SOLUBLE ST2 IS AFFECTED BY PULMONARY HYPERTENSION SEVERITY IN PATIENTS UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
20. Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT study
21. DIAGNOSIS OF NECROTIC INTRAPLAQUE CORES BY DUAL ENERGY CORONARY COMPUTED TOMOGRAPHIC ANGIOGRAPHY IN VICTIMS OF SUDDEN CORONARY DEATH: VALIDATION TO A PATHOLOGIC GOLD STANDARD
22. A SIMPLE-TO-USE NOMOGRAM FOR PREDICTING 5-, 10- AND 15-YEAR SURVIVAL FOR ASYMPTOMATIC INDIVIDUALS UNDERGOING CORONARY ARTERY CALCIUM SCORING
23. Characterization and Prediction of Adverse Events From Intensive Chronic Heart Failure Management and Effect on Quality of Life: Results From the Pro-B-Type Natriuretic Peptide Outpatient-Tailored Chronic Heart Failure Therapy (PROTECT) Study
24. Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: The BIOCRT study
25. Quality of life outcomes in proton and photon treated pediatric brain tumor survivors
26. A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study
27. Characterization and Prediction of Adverse Events from Intensive Chronic Heart Failure Management with and without NT-proBNP Guidance: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study
28. INCREMENTAL VALUE OF CYSTATIN C BEYOND CONVENTIONAL MARKERS OF RENAL FUNCTION FOR PREDICTING CLINICAL RESPONSE IN PATIENTS RECEIVING CARDIAC RESYNCHRONIZATION THERAPY: THE BIOCRT STUDY
29. SUPERIORITY OF CORONARY SINUS CARDIAC BIOMARKER SAMPLING OVER PERIPHERAL VENOUS BLOOD FOR PROGNOSTICATION IN CARDIAC RESYNCHRONIZATION THERAPY: THE BIOCRT STUDY
30. Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control
31. Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15, and Highly-Sensitive Troponin T Measurements in Patients With Chronic Heart Failure
32. Aortic distensibility and its relationship to coronary and thoracic atherosclerosis plaque and morphology by MDCT: Insights from the ROMICAT Trial
33. A prospective trial of real-time magnetic resonance–guided catheter placement in interstitial gynecologic brachytherapy
34. Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: A 10-year single institution retrospective study
35. CORONARY SINUS LEVEL OF GALECTIN-3 IS A BETTER PREDICTOR THAN PERIPHERAL VENOUS LEVEL OF MAJOR ADVERSE CARDIAC EVENTS IN PATIENTS WITH CARDIAC RESYNCHRONIZATION THERAPY
36. SERIAL MEASUREMENT OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 7 PREDICTS CHRONIC HEART FAILURE OUTCOMES AND VENTRICULAR REMODELING: RESULTS FROM THE PROBNP OUTPATIENT TAILORED CHRONIC HEART FAILURE THERAPY (PROTECT) STUDY
37. Safety and Effectiveness of Oxaliplatin-Based Chemotherapy Regimens in Adults 75 Years and Older With Colorectal Cancer
38. CIRCULATING CONCENTRATIONS OF SOLUBLE ST2 IDENTIFY BENEFIT OF HIGH DOSE BETA BLOCKER IN CHRONIC HEART FAILURE: RESULTS FROM THE PROBNP OUTPATIENT TAILORED CHRONIC HEART FAILURE THERAPY (PROTECT) STUDY
39. SERIAL MEASUREMENT OF GALECTIN-3 PREDICTS CHRONIC HEART FAILURE OUTCOMES AND VENTRICULAR REMODELING: RESULTS FROM THE PROBNP OUTPATIENT TAILORED CHRONIC HEART FAILURE THERAPY (PROTECT) STUDY
40. A phase II trial of Sunitinib malate in recurrent and refractory ovarian, fallopian tube and peritoneal carcinoma
41. Prevalence and significance of subcentimeter hepatic lesions in patients with localized pancreatic adenocarcinoma
42. Influence of pericoronary adipose tissue on local coronary atherosclerosis as assessed by a novel MDCT volumetric method
43. Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.